Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · February 20, 2022

Risk of Infection, Hospitalisation, and Death After the Second Dose of COVID-19 Vaccine

The Lancet

 

Additional Info

The Lancet
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
Lancet 2022 Feb 04;[EPub Ahead of Print], P Nordström, M Ballin, A Nordström

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading